Stocks / GILD

GILD stock forecast

GILEAD SCIENCES INC · Healthcare · Drug Manufacturers - General

The model's rating

Outperform

GILD is rated Outperform as of November 18, 2026: its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth.

Changed from Greatly Outperform on November 5, 2026.

Premium adds the numeric score behind this label, the medium-term return forecast, and today's full Upfront Picks.

Where this rating comes from: The Upfront Model, whose picks have been recorded with a fingerprint the day they publish since September 18, 2026. See the record.

GILD is not among the 20 largest holdings published for 2026 Q4. See the portfolio

GILD against the S&P 500

PeriodGILDS&P 500 (SPY)
1 month+10.4%-4.7%
3 months+15.1%-4.8%
Year to date+40.1%+7.9%
1 year+36.1%+11.8%

Total return, dividends included.

Key numbers

Price$168.98
Market cap209.59 Billion
P/E (trailing 12 months)-54.5
P/S (trailing 12 months)6.8
P/B (latest quarter)16.2
Gross margin79.9%
Net profit margin-12.5%
Return on equity-21.7%
Beta0.4

As of October 30, 2026.

GILD and its closest peers

StockCompanyMarket capModel rating
AMGN AMGEN INC 240.11 Billion Outperform AMGN vs GILD
PFE PFIZER INC 159.94 Billion Greatly Outperform GILD vs PFE
BMY BRISTOL MYERS SQUIBB CO 121.75 Billion Greatly Outperform GILD vs BMY
MRK MERCK & CO INC 339.66 Billion Greatly Outperform MRK vs GILD
BIIB BIOGEN INC 37.16 Billion Greatly Outperform GILD vs BIIB
ABBV ABBVIE INC 505.56 Billion Outperform

Questions

What does the Upfront Investment model say about GILD?

The model rates GILEAD SCIENCES INC (GILD) "Outperform" as of November 18, 2026, which means its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth. The rating is a statistical forecast, not a recommendation to buy or sell.

How is the GILD rating produced?

A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.

Is GILD in the Upfront Investment model portfolio?

GILD is not among the 20 largest holdings published for 2026 Q4.

The rating is generated by The Upfront Model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.